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2 ICOS Corporation the domain (from “closed” to “open”) that alters the
shape and charge distribution of the upper surface and22021 20th Avenue SE
Bothell, Washington 98021 reorganizes the packing of the C-terminal helix, trans-
ducing a signal to other domains in the protein. Struc-
ture-based mutagenesis and biophysical studies of re-
combinant integrin I domains demonstrate the existenceSummary
of a dynamic equilibrium between closed and open
states and allosteric control of ligand affinity (Li et al.,Complement factor B is a 90 kDa protein consisting
1998; McCleverty and Liddington, 2003; Shimaoka etof three domains: a three-module complement control
al., 2000, 2001, 2002).protein, a von Willebrand factor A domain, and a
In the eponymous von Willebrand factor, which con-C-terminal serine protease (SP) domain that adopts a
tains three A domains (A1–A3), the MIDAS sequencedefault inactive (zymogen) conformation. The interac-
motifs are not completely conserved, and these do-tion between factor B and pathogen-bound C3b is
mains do not bind metal (Bienkowska et al., 1997). In-mediated by its A domain, triggering a conformational
deed, ligand recognition is centered on a different facechange in factor B that ultimately creates the “C3 con-
of the domain (one side of the  sheet; Huizinga etvertase” of the alternative complement pathway. We
al., 2002; Nishida et al., 2003; Romijn et al., 2001) andreport the crystal structure of the A domain from factor
involves much smaller tertiary changes. The A domainsB and show that it contains an integrin-like MIDAS
of integrins and vWF are the only members of the familymotif that adopts the “open” conformation typical of
whose three-dimensional structures have been de-integrin-ligand complexes, with an acidic residue (pro-
scribed thus far.vided by a fortuitous crystal contact) completing the
Factor B is a 90 kDa protein that plays a central rolecoordination of the metal ion. Modeling studies indi-
in the “alternative pathway” of complement activationcate that the factor B A domain can also adopt the
(Xu et al., 2001). It consists of three domains: a three-closed conformation, supporting the hypothesis that
module complement control protein (CCP) at the N ter-an “integrin-like switch” is conserved in complement
minus, a vWF A domain, and a C-terminal serine prote-proteins and perhaps in 60 other A domains found
ase (SP) domain. By electron microscopy, the proteinwithin the human proteome.
appears to be globular, with a diameter of 80 A˚ and a
three-lobe organization (Smith et al., 1984). Factor B
Introduction adopts a default inactive (zymogen) conformation, and
its proteolytic activity is enabled by binding to another
The von Willebrand factor (vWF) A domains are a family complement protein, C3b (a proteolytic fragment of the
of homologous 200 amino acid modules that were protein C3), that is bound to the surface of a bacterial
initially found in a number of extracellular and cell sur- pathogen. The interaction between factor B and C3b is
face proteins such as complement proteins and integ- Mg2 dependent and triggers a conformational change
rins, where they mediate protein-protein interactions in factor B that makes it susceptible to cleavage by
(Colombatti et al., 1993). More recent genomic analysis another enzyme, factor D. Factor D removes the three
(Whittaker and Hynes, 2002) has extended the family N-terminal CCP modules, which enhances the stability
to include ion channels, anthrax toxin receptors, and of the resulting “C3bBb” complex. C3bBb is called the
intracellular proteins involved in processes such as DNA “C3 convertase” of the alternative complement path-
repair and transcription; examples of A domains have way; it cleaves C3 to generate more C3b, thus amplifying
also been found in eubacteria and archaea. complement activation (reviewed in Xu et al., 2001).
The first crystal structure of a vWF A domain (often Recent work using a mimic of C3 derived from cobra
called an I domain in integrins), from the M subunit venom shows that in that case binding to factor B is
of integrin M2, revealed a Rossmann-like open / sufficient to create a functional convertase in the ab-
structure with a mostly parallel  sheet surrounded on sence of factor D cleavage (Xu et al., 2002). This sug-
two sides by  helices (Lee et al., 1995b). In integrin A gests that factor B can switch from a zymogen-like con-
domains, ligand binding is mediated by a Mg2 ion, formation to its active state without proteolytic cleavage
which coordinates three loops at the C-terminal end of by factor D, and it was inferred that binding of the A
the  sheet and a glutamate or aspartate from the ligand domain to C3b causes structural rearrangements that
(Emsley et al., 2000). This site is called the MIDAS (for activate the factor B serine protease activity allosteri-
metal ion-dependent adhesion site), and it comprises cally. The precise nature of this signal transduction
mechanism is unknown, but analogy with the integrin A
domain led to the proposal that ligand binding triggers*Correspondence: rlidding@burnham.org
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Figure 1. Structure-Based Sequence Alignment of Factor B with Complement C2 and the Integrin M and 2 A Domains
Secondary structure elements ( helices as rectangles,  strands as arrows) are indicated. The C-terminal helix, 7, is not seen in the factor
B map, but modeling studies suggest it exists in the closed conformation.
a downward shift of the C-terminal 7 helix that alters B A domains superpose closely (rmsd  0.5 A˚), the
flanking helices less well (rmsd  1–2 A˚) (Figure 2). Thethe packing of the A domain and SP domain (Xu et al.,
2002). 4-D loop and, especially, the 5-E loop are unusually
large and well ordered in our crystal structure. TheyWe report here the crystal structure of the A domain
from complement factor B and show that it contains an are present on the bottom face of the A domain and
presumably make contact with the CCP modules and SPintegrin-like MIDAS motif that adopts an open conforma-
tion that is identical to those observed in integrin-ligand domain. The C-terminal helix, 7, is largely disordered in
the factor B structure, although some patchy electroncomplexes, with an acidic residue (in this case provided
by a fortuitous crystal contact) completing the coordina- density is evident and has tentatively been modeled
by two alanine residues. This is the helix that shiftstion of the metal ion. Although we have been unable
so far to crystallize the closed conformation, modeling downwards by 10 A˚ in response to ligand binding in the
integrins (Emsley et al., 2000; Lee et al., 1995a). Massstudies indicate that it resembles the closed conforma-
tion of integrins. Our data thus support the hypothesis spectrometry of protein recovered from crystal trials
shows that the helix is not cleaved (see Experimentalthat the “integrin switch” is conserved in complement
proteins. Procedures). Modeling of the helix based on the integrin
structure shows that no steric clashes would occur in
the crystal lattice, suggesting that the flexibility of thisResults and Discussion
segment in factor B is an inherent property of the open
conformation. Indeed, the disordering of the C-terminalStructure of the Factor B A Domain
helix exposes the side chain of the only cysteine in theRecombinant human factor B A domain comprising resi-
domain, C267, which would otherwise be buried in thedues 229–448 was crystallized and its structure solved
hydrophobic core, thus rationalizing its reactivity (disul-to a resolution of 1.8 A˚ by using a new molecular replace-
fide-linked dimerization) in the recombinant protein (Wil-ment analysis tool, COMPANG (see Experimental Proce-
liams et al., 1999).dures). As expected, the protein adopts the vWF A do-
main fold, consisting of a central  sheet flanked on
both sides by amphipathic  helices (Figures 1 and 2). The MIDAS Site and Ligand Binding
In factor B, the MIDAS residues involved in metal ionThe domain is 40 A˚ high (from the top ligand binding
face to the opposite surface), 30 A˚ wide across the coordination adopt nearly identical conformations to
those observed in the liganded integrin A domains (Fig- sheet, and 35 A˚ broad, in agreement with electron
micrographs (Smith et al., 1982). ure 3A) (Emsley et al., 2000; Lee et al., 1995a; Shimaoka
et al., 2003). The metal ion is coordinated directly byBy homology with the integrin M A domain structure
(Lee et al., 1995b), strands are labeled A–F and helices S253 and S255 from loop 1, T328 from loop 2, and
two water molecules, at distances of 2.1  0.1 A˚. Two1–7 (Figure 1). The central  sheets of the M and factor
Factor B A Domain Structure
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Figure 2. C Stereo Diagram of the Factor B vWF A Domain Overlaid with the Integrin M A Domain in the Open Conformation
The factor B vWF A domain is represented by solid lines. N- and C termini and every 20th residue are labeled. The F-7 turn, the location of
which is a marker of the open conformation, is highlighted in bold.
aspartic acids, D251 (loop 1) and D364 (loop 3), make Mutagenesis studies have demonstrated the impor-
tance of acidic residues in C3b for binding to factor Bwater-mediated bonds to the metal. D364 lies within a
loop containing a TDG sequence. The glycine in this (Taniguchi-Sidle and Isenman, 1994). Thus, E736 and
E737, located near the amino terminus of the  chainloop undergoes a dramatic flip on switching from the
closed to open conformation in the integrins (Table 1). of C3, were mutated in turn to glutamine, causing a 40%
decrease in C3 binding to factor B in each case. InIn factor B, this loop closely superimposes with that of
the open conformation, and the torsion angles are very addition, formation of the C3bBb complex is Mg2 de-
pendent (Pillemer et al., 1953). The crystal structure ofsimilar. The side chain of an acidic residue (D346) from
another A domain in the crystal lattice completes the factor B described here is therefore likely to be an excel-
lent model for the C3b-bound state. The critical residuesoctahedral coordination of the bound metal. A similar
“ligand-mimetic” was observed in two crystal structures surrounding the MIDAS motif that presumably contrib-
ute to binding specificity have been investigated by mu-of integrin A domains, and these were shown to adopt
conformations identical to the authentic ligand-bound tagenesis. Note that although the integrin M2 binds
to a fragment of C3b (iC3b) via its A domain, the residuesstate (Emsley et al., 2000; Lee et al., 1995a; Shimaoka
et al., 2003). surrounding the MIDAS motif are very different, and the
Figure 3. Conformation of the MIDAS Motif and the F-7 Turn
(A) Superposition of the MIDAS motifs of factor B and 2 integrin A domains. The structures are superposed on their central  sheets. Color-
coding is as follows: factor B C, green; side chains, black; ligand mimetic, gold and red; 2 A domain C and side chains, white (semitranspar-
ent). The metal ion (“M”) is in purple, with coordinating oxygens from S253, S255, T328, and two water molecules (“W”) in red. The side chains
of D251 and D364 form water-mediated bonds to the metal ion.
(B) Overlay of the F-7 turns of factor B (red) with the open (translucent green) and closed (yellow) conformations of the integrin M I domain.
The C positions of analogous residues (M433 in factor B; F302 in M) are indicated.
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Table 1. Torsion Angles (φ, ) of MIDAS Loop 3
Closed Open
M 2 M 2 FACB
T 144, 150 142, 153 153, 169 160, 167 154, 169
D 115, 11 123, 23 94, 3 93, 4 99, 3
G 162, 158 165, 153 73, 27 74, 12 74, 6
binding determinants on iC3b are likely to be different. around residue L450. The crystal structure of the factor
B serine protease was recently determined (Jing et al.,Accordingly, mutating residues close to the MIDAS to
their M (Hourcade et al., 1999) or C2 (Tuckwell et al., 2000), and its N terminus is defined by a disulfide bridge
at residue C453. Thus, the linker between the domains1997) counterparts diminished the affinity of factor B for
C3b or affected specificity. appears to be minimal in the closed conformation, con-
sistent with a close packing of the serine protease do-One further marker of the open conformation is the
position of the tight turn (F-7) preceding the C-ter- main against the large loops at the base of the A domain.
Attempts to dock the domains in silico did not yield aminal helix. In integrins, the 10 A˚ shift of the C-terminal
helix on ligand binding requires a comparable shift of unique solution, but the SP active site and MIDAS motif
must lie at opposite poles of a two-domain dumbbell,this turn. Superposition of the central  sheets of the
integrin A domains and factor B (Figure 3B) demon- as previously proposed (Jing et al., 2000).
Our structural data increase the likelihood that C3bstrates that the position of this loop is almost identical
to that of the open conformation (rmsd  0.75 A˚) and binding to the MIDAS surface of the A domain triggers
a transition to the open conformation, leading to anvery different from that of the closed conformation
(rmsd  4.6 A˚). Thus, in all critical respects, the factor allosteric alteration of the binding surface with the serine
protease domain, as previously proposed (Xu et al.,B A domain appears to adopt the open, liganded confor-
mation. 2002). The CCP modules presumably resist this confor-
mational switch to some extent until they are cleavedSequence alignments with the integrin A domains and
secondary structure predictions clearly suggest the off by factor D. The cobra venom mimic of C3b likely
bypasses the requirement of factor D cleavage simplypresence of an amphipathic C-terminal helix, 7. It is
straightforward to build a 3-D model of the closed con- by binding more strongly to the open conformation of
the A domain. However, activation involves more thanformation based on comparisons between the open and
closed conformations of M and 2 A domains, in which a simple release of inhibitory constraints on the SP do-
main. Thus, neither Bb (A domain SP) nor the isolatedhelix 7 packs against the side of the domain (coordi-
nates available from the authors on request). This model SP domain has substantial proteolytic activity (Sanchez-
Corral et al., 1990) in the absence of C3b. Indeed, thesuggests that the end of the C-terminal helix occurs
Figure 4. MALDI-TOF Mass Spectrometry of Factor B A Domain Protein Recovered from Crystallization Trials
For details, see Experimental Procedures.
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crystal structure of recombinant SP (Jing et al., 2000) Table 2. Data Collection and Model Refinement Statistics
shows that the active site oxyanion hole displays a zy-
X-ray source SSRL 7-1
mogen-like conformation. These data suggest that the Wavelength (A˚) 1.08/1.5418
open conformation of the A domain participates actively Space group P63
in stabilizing the active conformation of the SP domain, Maximum resolution (A˚) 1.8
Independent reflections 21009perhaps by providing a binding surface that was inac-
Multiplicitya 5.6 (5.6)cessible in the closed conformation. An alternative to a
Completeness (%) 99.4 (100.0)purely allosteric model is one in which C3b binds to
Rmerge (%)b 5.0 (38.5)both the A domain and the SP domain, and there is I/	I 9.2 (2.0)
some evidence for such an interaction (Jing et al., 2000).
Model refinement
Resolution range (A˚) 25–1.8Implications for C2
Number of nonhydrogen atoms 1687
In the classical complement pathway, C2 is the struc- Rwork (%)c 21.0
tural and functional counterpart of factor B (Smith et al., Rfree (%)d 25.9
Rmsd from ideal bond length (A˚) 0.0101982, 1984). The proteins have 39% sequence identity
Rmsd from ideal bond angles (
) 1.39overall and 33% identity over the A domains. The MIDAS
Average B factor (A˚2) 34.4motif is strictly conserved, and C2 binds C4b, the coun-
Rmsd in B factors main/side chain (A˚2) 2.73/3.89terpart of C3b, in a Mg2-dependent fashion—a process
a Values for the outermost resolution shell are given in parentheses.which, as in factor B, leads to activation of the SP do-
b Rmerge  100  hj |Ihj  Ih|/hjIhj, where Ih is the weighted meanmain. Given the functional similarities between C2 and
intensity of the symmetry-related reflections Ihj.factor B and the high degree of sequence identity, it
c Rwork  100  hkl |Fobs  Fcalc|/hkl Fobs, where Fobs and Fcalc are theseems likely that C4b binding will lead to similar struc- observed and calculated structure factors, respectively.
tural changes in the C2 A domain. Homology modeling d Rfree is the Rwork calculated using a randomly selected 10% sample
of the C2 A domain based on the factor B A domain of the reflection data omitted from the refinement.
allows the interpretation of biochemical experiments
performed on C2. As expected, mutation of the DxSxS
residues leads to greatly reduced hemolytic activity (Ho- been recently characterized. The copines are a family
riuchi et al., 1991). Another study found that reaction of intracellular phospholipid binding proteins, although
with the thiol-blocking agent p-chloromercuribenzoate their cellular function is unclear. The A domain contains
(p-CMB) abolished the hemolytic activity of C2 by re- a perfect MIDAS motif (loop 1 is DxTxS), and these
acting with the free cysteine at position 241 of C2 domains bind to Mg2 and Mn2 in preference to Ca2
(Parkes et al., 1983). This cysteine is located in loop 1 (Tomsig and Creutz, 2000), as expected for a classic
of the MIDAS motif (DCSxS). It is likely that covalent MIDAS motif. Recently, the same group has shown using
attachment of a bulky group disrupts Mg2 coordination. a two-hybrid screen that the A domain binds to a large
In the same study (Parkes et al., 1983), exposure of C2 number of intracellular proteins. However, the only inter-
to iodine resulted in stabilization of the C4b2a con- action that was Mg2 dependent was with collagen (an
vertase. The effect of iodine was demonstrated to proceed extracellular molecule, so its biological relevance is un-
through a reaction with the free thiol group of the same clear; Tomsig et al., 2003). It is possible that the A domain
cysteine. The cysteine is buried 6 A˚ from the MIDAS in this case binds an acidic residue intramolecularly and
surface. It is possible that modification of the cysteine thus plays a regulatory role, as suggested in certain
pushes loop 1 toward loop 2; this is the direction that integrins (Alonso et al., 2002).
loop 2 moves in the transition from closed to open (it Some A domains clearly do not bind metal. These
enables the Mg2 ion to coordinate directly residues include the three domains of von Willebrand factor, as
from both loops). Thus iodination may stabilize the open noted above: two of the domains (A1 and A2) have a
conformation. basic residue replacing the second serine of the DxSxS
motif, which makes lack of metal binding unsurprising.
The vWF A3 domain has perfect L1 and L2 MIDAS se-Implications for Other A Domains
A recent analysis identified 135 vWF A domains in the quences, but L3 is replaced by the sequence VTD. Al-
though the three-dimensional structure brings the threo-human proteome (Whittaker and Hynes, 2002), the ma-
jority of which are found within extracellular proteins. nine side chain into the correct orientation to complete
the coordination of a metal ion, none is bound, presum-Of these, 70 appear to have “perfect” MIDAS motifs,
defined by the DxSxS…T…TDG motif (allowing for the ably owing to the reduction in negative charge from
aspartate to threonine (Bienkowska et al., 1997). Thus,substitution of S for T), and these are found in proteins as
diverse as the anthrax toxin receptor family, ion channel a minor alteration to the MIDAS motif is sufficient in this
case to disable metal binding, and we predict that mostsubunits, and protease receptors. We expect that most
of these will bind Mg2 and bind ligand in a Mg2-depen- of the vWF A domains that do not contain a perfect
MIDAS motif do not bind metal.dent fashion. This certainly holds for the integrin family.
A recent study has shown that the binding of anthrax One notable exception is the integrin  subunit. The
 subunits of integrins contain an A domain with a varianttoxin to its receptor is Mg2 dependent and is critically
dependent on an aspartic acid in the toxin (Bradley et of the MIDAS motif. Loop 1 is invariant (DxSxS); loop 2
contributes a glutamate (from a strictly conserved PEGGal., 2001; Rosovitz et al., 2003).
One intracellular example of an A domain family has motif) rather than threonine to metal coordination (note
Structure
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were analyzed on SDS-PAGE and then pooled and concentrated tothat the definition of loop 2 for the integrin -A domain
7–8 mg/ml prior to crystallization trials. Typically, 30–40 mg of pureis incorrect in Whittaker and Hynes [2002]); and loop 3
A domain was obtained per liter of bacterial culture.is S(T)DX, where X is not glycine. Nevertheless, these
Crystals of the factor B A domain were grown by vapor diffusion
domains bind a metal ion (the presence of glutamate in at 4
C using the sitting drop method. Each drop consisted of 1 l
loop 2 alters the metal specificity, and Ca2 functions of the reservoir solution mixed with 1 l of protein solution. Crystals
appeared after 2–3 days in drops equilibrated against a reservoiras well as Mg2) and bind ligand in a metal-dependent
solution containing 0.05 M CsCl, 30% (v/v) Jeffamine M-600, andfashion, forming a metal bridge to an aspartic acid in
0.1 M MES (pH 6.5) and grew to full size in 2 weeks. The best crystalsthe ligand (Xiong et al., 2002). Ligand binding involves
had dimensions 0.3 mm  0.3 mm  0.2 mm. The molecular weightan alteration in metal ion coordination, but it is currently
of protein recovered from crystallization trials was determined by
unclear whether this alteration triggers a conformational matrix-assisted laser adsorption/ionization-mass spectroscopy
switch in the domain that is analogous to the  subunit (MALDI-MS) spectra using a Voyager DE-PRO MALDI-TOF (time-
of-flight) mass spectrometer (Perseptive Biosystems, Framingham,integrin switch (Liddington, 2002).
MA), linear mode, and SA (3,5-dimethoxy-4-hydroxycinnamic acid)Our new data revealing the existence of an integrin-
as a matrix (Figure 4). Protein was dialyzed against distilled waterlike ligand-bound open conformation for the factor B A
and diluted into 0.1% aqueous TFA. Peaks were assigned using thedomain raise the question of whether other A domains
program Voyager Data Explorer v.4.0. The estimated MW (25,109)
can adopt a similar ligand-bound conformation that is in good agreement with the predicted value (25,005), showing
could provide a common structural pathway for ligand- that no cleavage of the protein occurred during crystallization.
regulated changes in activity. There are no published
Data Collection and Processingdata on conformational changes for members of the
All X-ray diffraction data were collected at 100 K. Crystals werevWF A domain family other than the integrins. We note
frozen by rapid immersion in liquid nitrogen using the mother liquorhowever that in all cases in which the A domain contains
alone as a cryoprotectant. The data were indexed and measured
a perfect MIDAS motif, the loop 3 sequence is T(S)DG. with MOSFLM (A. Leslie, personal communication); scaling and sub-
The threonine forms a hydrogen bond to the DxSxS sequent data handling were carried out with the CCP4 suite of
aspartate (in both the open and closed conformations) programs (CCP4, 1994). The crystals adopt space group P63, and
the structure was determined using a single large crystal with celland may be important for correct orientation of the
dimensions a  72.6 A˚, c  76.1 A˚. A 2.3 A˚ data set was collectedaspartate side chain. The preference for glycine could
in-house with a Rigaku RU-H3R X-ray generator and an R-Axis IVbe explained by the requirement for flexibility at this
image plate. A 1.8 A˚ data set from the same crystal was later col-
position, since the switch in metal coordination involves lected on beam line 7-1 at the Stanford Synchrotron Radiation Labo-
a 4 A˚ displacement of the glycine C and a major change ratory (SSRL) using a MAR345 image plate. The asymmetric unit
of its torsion angles from  strand to left-handed  helix contains one molecule of factor B A domain, assuming a solvent
content of 47%.(Table 1). Thus, we hypothesize that the A domains that
contain a perfect MIDAS motif will both bind metal and
Structure Determinationundergo an integrin-like switch.
Initial attempts to determine the structure by molecular replacement
were unsuccessful. A number of different programs were tried in-
cluding AMoRe (Navaza, 1994), Molrep (Read, 2001; Vagin andExperimental Procedures
Teplyakov, 1997), and the molecular replacement package within
CNS (Brunger et al., 1998), using all the A domain structures currentlyProtein Expression, Purification, and Crystallization
available in either the open/liganded or closed/unliganded confor-The cDNA region encoding the vWF A domain of human factor B
mations as search models. A search model consisting of the well-(amino acids 229–448) was amplified and cloned into the vector
conserved central  sheet motif also did not yield a clear solution.pGEX-2T (Pharmacia Biotech) as described by Williams et al. (1999).
Finally, the cluster analysis program COMPANG (Urzhumtseva andA point mutant, C267A, was used, which prevented problems asso-
Urzhumtsev, 2001) was run with the output files obtained from allciated with disulfide-linked dimerization at the high protein concen-
the CNS cross-rotation function calculations. A clear peak in thetrations required for crystallization (Williams et al., 1999). The recom-
cluster histogram was observed with the angular cut-off level setbinant A domain was expressed as a Glutathione S-transferase
to 4.5
. Translation searches were performed in CNS (Brunger etfusion protein in BL21*pLysS strain E. coli (Invitrogen). Cells were
al., 1998) with the rotation solutions comprising this cluster. Thegrown in LB media containing 34 g/ml chloramphenicol and 100
molecular replacement solution with the highest correlation coeffi-g/ml carbicillin and were subsequently induced for 5 hr with 1 mM
cient was obtained using the open conformer of M (Lee et al.,isopropyl--D-thiogalactopyranoside (IPTG) at 37
C. Cells were har-
1995b), and this model was used as a starting point for refinement.vested by centrifugation and frozen at 70
C until required.
Cell pellets from 500 ml of culture were thawed at room tempera-
ture and resuspended in 30 ml lysis buffer consisting of Dulbecco’s Refinement
All refinement was carried out in CNS (Brunger et al., 1998), withphosphate-buffered saline (PBS) (pH 7.4) with the addition of 1 mM
AEBSF and 1% (v/v) Triton X-100. The samples were then sonicated 10% of reflections omitted from the refinement for calculating the
Rfree. After one round of simulated annealing and conjugate gradienton ice (eight cycles of pulse 30 s and wait 30 s), and the lysate
was centrifuged at 39,000  g for 30 min to remove debris. The minimization, the Rwork was 44.6% and the Rfree 49.8%. A sigma-
weighted 2Fo-Fc electron density map was calculated (Read, 1986)supernatant was incubated with 10 ml Glutathione-Sepharose 4B
(Pharmacia Biotech) for 30 min at room temperature, and the beads and subjected to prime-and-switch phasing with RESOLVE (Terwil-
liger, 2000) to reduce model bias, and a new 2Fo-Fc map was calcu-were then washed with at least 100 ml PBS, 1% Triton X-100 fol-
lowed by 50 ml PBS. The beads were then resuspended in 30 ml lated with the improved phases. Inspection of this new map in O
(Jones et al., 1991) showed that many areas of the model were inPBS, 60 units of thrombin (Sigma-Aldrich) was added, and the mix-
ture was incubated with gentle agitation at room temperature for poor density. Consequently, surface loops connecting secondary
structure elements and  helices 2, 3, 5, and 7 were removed.1.5 hr. The thrombin-cleaved A domain, which includes two residues
(GS) from the vector at the N terminus, was eluted and dialyzed After another cycle of refinement, the model (consisting of all six 
strands [A–F] forming the central sheet and helices 1, 4, andthoroughly against 200 mM NaCl, 5 mM MgCl2, and 20 mM Tris-HCl
(pH 8.0). After dialysis, the recombinant protein was concentrated 6) had an Rwork of 43.3% and an Rfree of 47.0%. A 2Fo-Fc map calcu-
lated at this point was readily interpretable, and a strong peak atto approximately 5 mg/ml and further purified by gel filtration on a
Superdex 200 HR 10/30 column (Pharmacia Biotech). Peak fractions the MIDAS site in the difference Fourier indicated the presence of
Factor B A Domain Structure
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a metal ion. Initially this peak was modeled as a Mg2 ion owing to ment component C2. Evidence for a C4b binding site. J. Immunol.
147, 584–589.the presence of 5 mM MgCl2 in the protein buffer, but despite a
refined B factor of 10 A˚2 for the metal ion, a strong positive Fo-Fc Hourcade, D.E., Mitchell, L.M., and Oglesby, T.J. (1999). Mutations
difference peak was observed. Furthermore, an anomalous differ- of the type A domain of complement factor B that promote high-
ence Fourier (  1.08 A˚) showed a significant signal, inconsistent affinity C3b-binding. J. Immunol. 162, 2906–2911.
with the presence of a Mg2 ion. Since the A domain is known to
Huizinga, E.G., Tsuji, S., Romijn, R.A., Schiphorst, M.E., de Groot,
have an affinity for a number of different divalent cations (Fishelson
P.G., Sixma, J.J., and Gros, P. (2002). Structures of glycoprotein
et al., 1983; Lew et al., 1975; Wardlaw et al., 1958) that may have
Ibalpha and its complex with von Willebrand factor A1 domain.
been introduced as impurities during expression and purification of
Science 297, 1176–1179.
the protein, attempts to model other cations were made. As Mn2
Jing, H., Xu, Y., Carson, M., Moore, D., Macon, K.J., Volanakis, J.E.,accounted for the density, had a reasonable B factor after refinement
and Narayana, S.V.L. (2000). New structural motifs on the chymo-(B 22.7 A˚2), and is expected to have a significant anomalous signal
trypsin fold and their potential roles in complement factor B. EMBOat   1.08 A˚, this ion has been included in the final model. However,
J. 19, 164–173.the possibility that the density is due to another transition metal,
such as Ni2, or a mixed population of metal ions, cannot be ruled Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjelgaard, M. (1991). Im-
out. Our previous experience with A domains crystallized in the proved methods for building protein models into electron density
presence of different metals suggests that, although some metals maps and the location of errors in these models. Acta Crystallogr.
may favor either the open or closed conformation, they do not signifi- A47, 110–119.
cantly alter the details of a given conformation (Emsley et al., 2000). Lee, J.-O., Bankston, L.A., Arnaout, M.A., and Liddington, R.C.
Refinement progressed with repeated cycles of simulated anneal- (1995a). Two conformations of the integrin A-domain (I-domain): a
ing, conjugate gradient minimization, and B factor refinement pathway for activation? Structure 3, 1333–1340.
(Brunger et al., 1998) interspersed with manual model building in O
Lee, J.-O., Rieu, P., Arnaout, M.A., and Liddington, R.C. (1995b).(Jones et al., 1991). At a later stage in the refinement, the acquisition
Crystal structure of the A-domain from the the  subunit of integrinof a higher resolution data set allowed the structure determination
CR3 (CD11b/CD18). Cell 80, 631–635.to be extended to a resolution of 1.8 A˚. Water molecules were added
Lew, F.T., Yukiyama, Y., Waks, H.S., and Osler, A.G. (1975). Activa-at positions corresponding to peaks higher than 3 	 in the Fo-Fc
tion of the alternative (properdin) pathway by divalent cations. J.difference map and within 2.6–3.1 A˚ of at least two hydrogen donors
Immunol. 115, 884–888.or acceptors. The refined model includes residues 243–432 of factor
B, 192 water molecules, and a manganese ion. The C-terminal helix Li, R., Rieu, P., Griffith, D.L., Scott, D., and Arnaout, M.A. (1998).
(7) is largely disordered, although density for two residues of the Two functional states of the CD11b A-domain: correlations with key
helix, modeled as alanines, was apparent in the 2Fo-Fc maps. The features of two Mn2-complexed crystal structures. J. Cell Biol.
overall geometry of the model is good, with 90.4% of nonglycine 143, 1523–1534.
residues in the most favored region of the Ramachandran plot (Ra- Liddington, R.C. (2002). Will the real integrin please stand up? Struc-
makrishnan and Ramachandran, 1965). The final Rwork of the model ture 10, 605–607.
is 21.0% and the Rfree is 25.9%. Details of the refinement statistics
McCleverty, C., and Liddington, R.C. (2003). Structure-function stud-are presented in Table 2.
ies of allostery in the integrin M I domain. Biochem. J. 372, 121–127.
Navaza, J. (1994). AMORE—an automated molecular replacement
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